mProX™ Human ABCC2 Stable Cell Line
- Product Category:
- Membrane Protein Stable Cell Lines
- Subcategory:
- Transporter Cell Lines
To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.
Lot Number
Made to Order Inquiry
InquiryBased on this stable cell line, we also provide cell-based in vitro assays to evaluate the effects of your compounds or antibodies.
Product Information
Product Properties
Protocols
Please visit our protocols page.
Customer Reviews
Ashley
Verified Customer
Stephanie
Verified Customer
Any questions about our products? Please visit our frequently asked questions page.
Published Data
Fig.1 Immunocytochemical staining of ABCC2 expression.
ABCC2 expression was stained immunocytochemically in three (×200) cells using the SP technique, DAB staining, and hematoxylin counterstaining. (a) Blank control; (b) CDDP-resistant CNE2-CDDP cells; (c) parental cell line CNE2; and (d) CDDP-5Fu-resistant CNE2-CDDP-5Fu cells. ABCC2 protein is found in the cytoplasm in the black arrow and in the nucleus in the red arrow.
Ref: Xie, Si Ming, et al. "Association of ABCC2 and CDDP-resistance in two sublines resistant to CDDP derived from a human nasopharyngeal carcinoma cell line." Journal of oncology 2010 (2010).
Pubmed: 20628484
DOI: 10.1155/2010/915046
Research Highlights
The body has a variety of broad specificity transporters in its excretory organs and several epithelial blood-tissue barriers to aid in the removal of ambient toxins and metabolic waste products.
van der Schoor, Lori WE, et al. "New insights in the biology of ABC transporters ABCC2 and ABCC3: impact on drug disposition." Expert opinion on drug metabolism & toxicology 11.2 (2015): 273-293.
Pubmed:
25380746
DOI:
10.1517/17425255.2015.981152
It has been discovered that certain human malignancies overexpress multidrug resistance-associated protein 2 (ABCC2), an ATP-binding cassette multidrug resistance transporter. According to this study, cisplatin (DDP)-resistant A549 cells (A549/DDP) also had increased expression of ABCC2.
Chen, Yun, et al. "Increased ABCC2 expression predicts cisplatin resistance in non-small cell lung cancer." Cell Biochemistry and Function 39.2 (2021): 277-286.
Pubmed:
32815556
DOI:
10.1002/cbf.3577